The Consent Order requires Bogdana to cease advertising that its Cholestaway supplement significantly effects cholesterol, fat, or triglycerides, and can result in significant weight loss. It is also prohibited from using the Cholestaway trade name. In the distribution of Flora Source, the company is prohibited from making claims that the product reduces the risk of illness, including AIDS, and that it has weight loss effects. The company must also label any television paid programming as advertisements, and keep records of all advertisements, to be made available to the FTC for inspection.

http://www.mlmlegal.com/legal-cases/Bogdana_Corp_Final1771D66.php